CEO of the Year is J. Joseph Kim | president, co-founder and CEO | Inovio Pharmaceuticals
Here are several snippets from Philadelphia Business Journal:
In just 10 years, Dr. J. Joseph Kim has built his business from a startup vaccine development business in the University City Science Center incubator into a publicly traded company with 40 employees in Blue Bell.
While the young company, originally known as Viral Genomix, was in the incubator, Kim and his co-founder Dr. David Weiner began pre-clinical development of a class of drugs for treatment of HIV, cancer and inflammatory diseases using intellectual property they licensed from the University of Pennsylvania. Their progress enabled them to successfully raise $40 million and bring the company out of incubation within four years.
Post a Comment